Shopping Cart
Remove All
Your shopping cart is currently empty
GMA-161
Catalog No. T9901A-756 Copy Product Info
🥰Excellent
GMA-161 is a humanized IgG1 antibody targeting Fcγ receptor III (CD16). It holds potential for researching autoimmune diseases. For an isotype control, refer to Human IgG1 kappa, Isotype Control.
GMA-161
Copy Product Info🥰Excellent
Catalog No. T9901A-756
GMA-161 is a humanized IgG1 antibody targeting Fcγ receptor III (CD16). It holds potential for researching autoimmune diseases. For an isotype control, refer to Human IgG1 kappa, Isotype Control.
GMA-161
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Inquiry | Inquiry | |
| 5 mg | Inquiry | Inquiry | Inquiry |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Storage & Solubility Information
| Description | GMA-161 is a humanized IgG1 antibody targeting Fcγ receptor III (CD16). It holds potential for researching autoimmune diseases. For an isotype control, refer to Human IgG1 kappa, Isotype Control. |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Target | CD16 |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice. |
Calculator
Preview
Related Tags: buy GMA-161 | purchase GMA-161 | GMA-161 cost | order GMA-161
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.